olympia glp-1 Agonists for Weight Loss GLP-1 Agonists for Weight Loss

While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication ...

Best results with consistent, daily use for 3-6 months

Only 40% of 2023 initiators remained on therapy after a year compared to 34% of 2022 initiators and 33% of 2021 initiators

Patient accounts on semaglutide and tirzepatide for PCOS: weight loss, better insulin control and restored cycles with common digestive side effects and medical oversight needed.

On July 25, 2023, China National Medical Products Administration (NMPA) approved Beinaglutide Injection (Feisumei), a glucagon-like peptide-1 receptor agonist (GLP-1-RA), for weight loss.

ChemAIRS is an artificial intelligence program that optimizes retrosynthesis, the process of working backward from a target molecule to determine the best sequence of chemical steps to synthesize it